Cervical Intraepithelial Neoplasia 3
Pipeline by Development Stage
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (4)
Total enrollment: 135 patients across 4 trials
Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3
Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.
Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation
Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.